Fecal microbiota transplantation in ulcerative colitis: mucosal immune mechanisms and precision microbiota therapy - Top-Institutions - MDSpire

Exploring Mucosal Immune Mechanisms and Targeted Microbiota Therapy in Ulcerative Colitis through Fecal Microbiota Transplantation

  • By

  • Enhui Lu

  • Miao Zhang

  • Yuanyang Zhao

  • Hai Meng

  • Zhixuan Xu

  • July 20, 2026

Share

Top Institutions in Gastroenterology

Brief introduction explaining scope and methodology.

  • #1

    Weill Cornell Medicine / NewYork-Presbyterian Hospital
    Weill Cornell Medicine / NewYork-Presbyterian Hospital

    New York, NY

    Key Differentiators

    • Gastroenterology
    • Mucosal Immunology

  • #2

    University of Chicago Medicine
    University of Chicago Medicine

    Chicago, IL

    Key Differentiators

    • Gastroenterology
    • Mucosal Immunology

Original Source(s)

Fecal microbiota transplantation in ulcerative colitis: mucosal immune mechanisms and precision microbiota therapy

  • by Enhui Lu, Miao Zhang, Yuanyang Zhao, Hai Meng, Zhixuan Xu

  • July 20, 2026

Related Content

Host–microbial co-metabolites: from biogenesis to immunomodulation and implications for health and disease

Association between OLD and IBD: a systematic review and meta-analysis

Noncanonical NF-κB pathway driven inflammation across multiple cellular compartments identifies NIK as a therapeutic target for inflammatory bowel disease